CHEMED CORPORATION Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect
CHEMED CORPORATION (CHE) reported Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect of -$34.29 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect · last filed 2026-07-31
- CHEMED CORPORATION cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2026-03-31 was -$57.66M.
- CHEMED CORPORATION cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2025-03-31 was -$4.47M, a 109.05% decline year-over-year.
- CHEMED CORPORATION cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2024-03-31 was $49.39M.
- CHEMED CORPORATION cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2023-03-31 was -$16.07M.
- CHEMED CORPORATION cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2025 was -$103.83M.
- CHEMED CORPORATION cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2024 was -$85.61M, a 145.10% decline from fiscal 2023.
- CHEMED CORPORATION cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2023 was $189.83M, a 360.41% increase from fiscal 2022.
- CHEMED CORPORATION cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2022 was $41.23M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$34.29M 10-Q · filed 2026-07-31 | |||
| 2026-03-31 | -$57.66M 10-Q · filed 2026-04-28 | |||
| 2025-12-31 | -$103.83M 10-K · filed 2026-02-27 | |||
| 2025-09-30 | -$48.60M 10-Q · filed 2025-10-31 | |||
| 2025-06-30 | $71.55M 10-Q · filed 2026-07-31 | |||
| 2025-03-31 | -$4.47M 10-Q · filed 2026-04-28 | |||
| 2024-12-31 | -$85.61M 10-K · filed 2026-02-27 | |||
| 2024-09-30 | -$25.51M 10-Q · filed 2025-10-31 | |||
| 2024-06-30 | -$41.05M 10-Q · filed 2025-07-31 | |||
| 2024-03-31 | $49.39M 10-Q · filed 2025-04-28 | |||
| 2023-12-31 | $189.83M 10-K · filed 2026-02-27 | |||
| 2023-09-30 | $99.02M 10-Q · filed 2024-11-01 | |||
| 2023-06-30 | $85.80M 10-Q · filed 2024-07-26 | |||
| 2023-03-31 | -$16.07M 10-Q · filed 2024-04-29 | |||
| 2022-12-31 | $41.23M 10-K · filed 2025-02-28 | |||
| 2022-09-30 | -$25.11M 10-Q · filed 2023-10-27 | |||
| 2022-06-30 | -$23.25M 10-Q · filed 2023-07-28 | |||
| 2022-03-31 | -$14.73M 10-Q · filed 2023-04-28 | |||
| 2021-12-31 | -$129.78M 10-K · filed 2024-02-29 | |||
| 2021-09-30 | -$133.93M 10-Q · filed 2022-11-02 | |||
| 2021-06-30 | -$70.56M 10-Q · filed 2022-07-29 | |||
| 2021-03-31 | $47.48M 10-Q · filed 2022-04-29 | |||
| 2020-12-31 | $156.52M 10-K · filed 2023-02-27 | |||
| 2020-09-30 | $106.61M 10-Q · filed 2021-11-01 | |||
| 2020-06-30 | $14.22M 10-Q · filed 2021-07-30 | |||
| 2020-03-31 | $22.79M 10-Q · filed 2021-04-30 | |||
| 2019-12-31 | $1.33M 10-K · filed 2022-02-28 | |||
| 2019-09-30 | $4.24M 10-Q · filed 2020-11-04 | |||
| 2019-06-30 | -$1.51M 10-Q · filed 2020-07-31 | |||
| 2019-03-31 | $3.94M 10-Q · filed 2020-05-01 | |||
| 2018-12-31 | -$6.29M 10-K · filed 2021-02-26 | |||
| 2018-09-30 | $56.34M 10-Q · filed 2019-11-04 | |||
| 2018-06-30 | $1.55M 10-Q · filed 2019-07-31 | |||
| 2017-12-31 | -$4.19M 10-K · filed 2020-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Option Care Health, Inc. (OPCH) | United States | $3.602B | 20.52 |
| Aveanna Healthcare Holdings, Inc. (AVAH) | United States | $2.703B | 7.22 |
| Addus HomeCare Corp (ADUS) | United States | $2.129B | 17.80 |
| BrightSpring Health Services, Inc. (BTSG) | United States | $11.078B | 37.65 |
| AdaptHealth Corp. (AHCO) | United States | $0.759B | -6.22 |